IGF1 and obesity due to melanocortin 4 receptor deficiency: Insulin/IGF signaling is reported to be dysregulated in obesity, diabetes, and breast cancer underscoring intricate overlaps in the underlying metabolic abnormalities and disease spectrum [39].